Biotech Pullback Makes Bargains Out Of Alexion, Flexion, Clovis, Tesaro, and Incyte

After a very strong year, the biotech sector has suffered an 8% pullback over the past 5 weeks. Todd Hagopian, whose biotech portfolio is up 38% this year, believes that the recent pullback has created bargains in Alexion, Flexion, Clovis, Tesaro, and Incyte.